Luana Vittoria Bauso

Dr. Luana Vittoria Bauso

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2024 in Biology
Verified
Journal Article
Open access
PDF file
LBLuana Vittoria Bauso
Luana Vittoria Bauso
VFValeria La Fauci
Valeria La Fauci
CLClelia Longo
Clelia Longo
GCGiovanna Calabrese
Giovanna Calabrese
Large bone defects are the leading contributor to disability worldwide, affecting approximately 1.71 billion people. Conventional bone graft treatments show several disadvantages that negatively impact their therapeutic outcomes and limit their clinical practice. Therefore, much effort has been made to devise new and more effective approaches. In this context, bone tissue engineering (BTE), involving the use of biomaterials which are able to mimic the natural architecture of bone, has emerged as a key strategy for the regeneration of large defects. However, although different types of biomaterials for bone regeneration have been developed and investigated, to date, none of them has been able to completely fulfill the requirements of an ideal implantable material. In this context, in recent years, the field of nanotechnology and the application of nanomaterials to regenerative medicine have gained significant attention from researchers. Nanotechnology has revolutionized the BTE field due to the possibility of generating nanoengineered particles that are able to overcome the current limitations in regenerative strategies, including reduced cell proliferation and differentiation, the inadequate mechanical strength of biomaterials, and poor production of extrinsic factors which are necessary for efficient osteogenesis. In this review, we report on the latest in vitro and in vivo studies on the impact of nanotechnology in the field of BTE, focusing on the effects of nanoparticles on the properties of cells and the use of biomaterials for bone regeneration.

Verified
Journal Article
Open access
PDF file
LBLuana Vittoria Bauso
Luana Vittoria Bauso
VFValeria La Fauci
Valeria La Fauci
SMSerena Munaò
Serena Munaò
DBDesiree Bonfiglio
Desiree Bonfiglio
AAAlessandra Armeli
Alessandra Armeli
GCGiovanna Calabrese
Giovanna Calabrese
Cancer is one of the leading causes of morbidity and death worldwide, making it a serious global health concern. Chemotherapy, radiotherapy, and surgical treatment are the most used conventional therapeutic approaches, although they show several side effects that limit their effectiveness. For these reasons, the discovery of new effective alternative therapies still represents an enormous challenge for the treatment of tumour diseases. Recently, anticancer peptides (ACPs) have gained attention for cancer diagnosis and treatment. ACPs are small bioactive molecules which selectively induce cancer cell death through a variety of mechanisms such as apoptosis, membrane disruption, DNA damage, immunomodulation, as well as inhibition of angiogenesis, cell survival, and proliferation pathways. ACPs can also be employed for the targeted delivery of drugs into cancer cells. With over 1000 clinical trials using ACPs, their potential for application in cancer therapy seems promising. Peptides can also be utilized in conjunction with imaging agents and molecular imaging methods, such as MRI, PET, CT, and NIR, improving the detection and the classification of cancer, and monitoring the treatment response. In this review we will provide an overview of the biological activity of some natural and synthetic peptides for the treatment of the most common and malignant tumours affecting people around the world.

25 May 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
LBLuana Vittoria Bauso
Luana Vittoria Bauso
CIChiara Imbesi
Chiara Imbesi
GIGasparo Irene
Gasparo Irene
GCGabriella Calì
Gabriella Calì
Alessandra BittoAlessandra Bitto
Alessandra Bitto
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus that causes coronavirus disease 2019 (COVID-19). The outbreak of this coronavirus was first identified in Wuhan (Hubei, China) in December 2019, and it was declared as pandemic by the World Health Organization (WHO) in March 2020. Today, several vaccines against SARS-CoV-2 have been approved, and some neutralizing monoclonal antibodies are being tested as therapeutic approaches for COVID-19 but, one of the key questions is whether both vaccines and monoclonal antibodies could be effective against infections by new SARS-CoV-2 variants. Nevertheless, there are currently more than 1000 ongoing clinical trials focusing on the use and effectiveness of antiviral drugs as a possible therapeutic treatment. Among the classes of antiviral drugs are included 3CL protein inhibitors, RNA synthesis inhibitors and other small molecule drugs which target the ability of SARS-COV-2 to interact with host cells. Considering the need to find specific treatment to prevent the emergent outbreak, the aim of this review is to explain how some repurposed antiviral drugs, indicated for the treatment of other viral infections, could be potential candidates for the treatment of COVID-19.

Verified
Journal Article
Open access
PDF file
PCPaola Campione
Paola Campione
Maria Giovanna RizzoMaria Giovanna Rizzo
Maria Giovanna Rizzo
LBLuana Vittoria Bauso
Luana Vittoria Bauso
IIIleana Ielo
Ileana Ielo
GMGrazia Maria Lucia Messina
Grazia Maria Lucia Messina
GCGiovanna Calabrese
Giovanna Calabrese
Bone defects restoration has always been an arduous challenge in the orthopedic field due to the limitations of conventional grafts. Bone tissue engineering offers an alternative approach by using biomimetic materials, stem cells, and growth factors that are able to improve the regeneration of bone tissue. Different biomaterials have attracted great interest in BTE applications, including the poly(3-hexylthiofene) (P3HT) conductive polymer, whose primary advantage is its capability to provide a native extracellular matrix-like environment. Based on this evidence, in this study, we evaluated the biological response of human adipose-derived mesenchymal stem cells cultured on P3HT thin polymer film for 14 days. Our results suggest that P3HT represents a good substrate to induce osteogenic differentiation of osteoprogenitor cells, even in the absence of specific inductive growth factors, thus representing a promising strategy for bone regenerative medicine. Therefore, the system provided may offer an innovative platform for next-generation biocompatible materials for regenerative medicine.

Verified
Journal Article
Open access
PDF file
AVAnna Martín Vilardell
Anna Martín Vilardell
VAVanesa Cantillo Alzamora
Vanesa Cantillo Alzamora
LBLuana Vittoria Bauso
Luana Vittoria Bauso
CXCristina Madrid Xufré
Cristina Madrid Xufré
Pavel KrakhmalevPavel Krakhmalev
Pavel Krakhmalev
NGNatalia Garcia-Giralt
Natalia Garcia-Giralt
Cu addition to alloys for biomedical applications has been of great interest to reduce bacterial growth. In situ-alloyed Ti6Al4V(ELI)-3at.%Cu was successfully manufactured by laser powder bed fusion (L-PBF). Even so, post-heat treatments are required to avoid distortions and/or achieve required/desired mechanical and fatigue properties. The present study is focused on the investigation of microstructural changes in L-PBF Ti6Al4V(ELI)-3at.%Cu after stress relieving and annealing treatments, as well as their influence on osteoblast and bactericidal behavior. After the stress relieving treatment, a homogenously distributed β phase and CuTi2 intermetallic precipitates were observed over the αʹ matrix. The annealing treatment led to the increase in amount and size of both types of precipitates, but also to phase redistribution along α lamellas. Although microstructural changes were not statistically significant, such increase in β and CuTi2 content resulted in an increase in osteoblast proliferation after 14 days of cell culture. A significant bactericidal behavior of L-PBF Ti6Al4V(ELI)-3at.%Cu by means of ion release was found after the annealing treatment, provably due to the easier release of Cu ions from β phase. Biofilm formation was inhibited in all on Cu-alloyed specimens with stress relieving but also annealing treatment.

Verified
Journal Article
Open access
PDF file
IIIleana Ielo
Ileana Ielo
LBLuana Vittoria Bauso
Luana Vittoria Bauso
ALAntonio Laezza
Antonio Laezza
PCPaola Campione
Paola Campione
Luigi FabianoLuigi Fabiano
Luigi Fabiano
GCGiovanna Calabrese
Giovanna Calabrese
Chronic wounds and post-operative complications generate significant biomedical challenges due to impaired tissue regeneration and persistent microbial infections, often aggravated by biofilm formation and antibiotic resistance. To address these issues, this study investigates the development and in vitro evaluation of electrospun polyvinylpyrrolidone (PVP) scaffolds embedded with silver nanoparticles (AgNPs), designed as multifunctional bioactive platforms for wound healing and implant applications. AgNPs were synthesized and uniformly incorporated into the PVP matrix using optimized electrospinning parameters, harnessing their antimicrobial and anti-inflammatory properties alongside the hydrophilicity, biocompatibility, and chemical stability of PVP. Structural and mechanical characterization, including Transmission Electron Microscopy (TEM) and Atomic Force Microscopy (AFM), homogenous nanoparticle dispersion, and favorable mechanical properties, such as Young’s modulus. In vitro cytotoxicity assays with fibroblast cell lines demonstrated good biocompatibility, while antibiofilm activity against Staphylococcus aureus revealed significant microbial inhibition. Overall, electrospun PVP+AgNPs scaffolds demonstrate strong potential as multifunctional biomaterials for wound healing and implant coating due to their synergistic capacity to support tissue regeneration and inhibit infection. These promising results highlight the need for further in vitro and in vivo investigation to confirm their therapeutic efficacy, biocompatibility, and long-term stability in physiological environments.